• Pyridostigmine, α7 nAChR, and Placental Necroptosis

  2026-08-25

  The reference study identifies placental necroptosis as a modifiable component of preeclampsia-like pathology and shows that pyridostigmine improves ischemia-associated outcomes through α7 nicotinic acetylcholine receptor signaling. Pharmacological blockade with α-bungarotoxin and comparison with necrostatin-1 provide a useful framework for separating cholinergic receptor dependence from general necroptosis inhibition.

• GST-Driven Lambda-Cyhalothrin Resistance in M. usitatus

  2026-08-24

  Dong et al. show that MuGSTs1-mediated glutathione S-transferase activity helps Megalurothrips usitatus withstand lambda-cyhalothrin by reinforcing antioxidant defenses. Pharmacological GST inhibition with diethyl maleate reduced antioxidant capacity and sharply increased insecticide sensitivity, providing causal evidence that redox protection contributes to resistance.

• TaqI Restriction Endonuclease Protocol Guide

  2026-08-24

  TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the TCG A recognition site. This guide covers setup, gel-based QC, and troubleshooting while defining the limits of the available product evidence; the enzyme is for scientific research use only, not diagnostic or medical applications.

• Lipo3K Transfection Reagent: Assay Reliability

  2026-08-23

  This scenario-based guide explains how Lipo3K Transfection Reagent, SKU K2705, can reduce transfection-related variability in viability, proliferation, cytotoxicity, gene expression, and RNA interference workflows. It connects product-supported performance characteristics with practical controls, timing, compatibility decisions, and vendor-selection criteria.

• Artesunate B3662: Reliable Cytotoxicity Assays

  2026-08-22

  Learn how Artesunate (SKU B3662) can be integrated into better-controlled viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects solvent handling, dose design, ferroptosis-focused interpretation, and supplier selection with quantitative product data and the distinction between relative and fractional viability.

• Scalable EPSC-Derived MSC Extracellular Vesicles

  2026-08-22

  Gong and colleagues developed a bioreactor-based platform that generates induced mesenchymal stem cells from extended pluripotent stem cells and continuously harvests their extracellular vesicles. The resulting vesicles showed primary MSC-EV-like characteristics and reduced fibrosis-associated injury in a bleomycin mouse model, supporting a more standardized route toward therapeutic EV manufacturing.

• Polystyrene Microplastics and DDIT4-Mediated Nephrotoxicity

  2026-08-21

  The reference study uses human pluripotent stem cell-derived kidney organoids to show that 1 μm polystyrene microplastics impair nephron development through DDIT4-associated inhibition of mTOR signaling, autophagy, and apoptosis. Its combination of a developmentally relevant 3D model, transcriptomic analysis, and DDIT4 silencing provides a useful framework for mechanistic nephrotoxicity research.

• Methotrexate in Psoriasis Assay Design

  2026-08-20

  Methotrexate is a folate antagonist with distinct cytostatic, apoptotic, and anti-inflammatory effects. This guide translates psoriasis pathway findings into a practical assay-design framework for separating DHFR inhibition from immune signaling changes.

• Cytochalasin B: Actin Mechanism and Research Use

  2026-08-20

  Cytochalasin B, also called NSC 107658, is a cell-permeable actin-disrupting mycotoxin used as a cytoskeletal research tool. Its reversible barbed-end activity supports mechanistic studies of actin filament dynamics, cell motility, division, phagocytosis, and glucose transport, but its broad pharmacology limits clinical interpretation.

• EDI3 in HER2 Therapy–Resistant Breast Cancer

  2026-08-19

  Keller et al. identify the glycerophosphodiesterase EDI3/GPCPD1 as a metabolically linked vulnerability in estrogen receptor-positive, HER2-positive breast cancer, including models resistant to HER2-targeted treatment. Their combination of patient-tissue analysis, pathway perturbation, genetic silencing, pharmacological inhibition, and in vivo testing supports EDI3 as a candidate target, while also defining important limits for translation.

• Anlotinib Hydrochloride: Angiogenesis Workflows

  2026-08-19

  Anlotinib hydrochloride provides a practical way to connect VEGFR2, PDGFRβ, and FGFR1 blockade with endothelial migration, tube formation, and ERK pathway readouts. This guide translates the compound’s anti-angiogenic profile and a notable desmoplastic small round cell tumor case report into reproducible cancer research workflows and troubleshooting decisions.

• CARMIL Membrane-Binding Domain and Actin Assembly

  2026-08-18

  Mooren and colleagues show that the CARMIL membrane-binding domain is an active regulator rather than a passive membrane tether: it recruits capping protein (CP) to lipid surfaces, then can dissociate after CP binding. The findings provide a biochemical explanation for how CARMIL may coordinate membrane localization, barbed-end uncapping, and Arp2/3-dependent actin assembly.

• MLN8237 (Alisertib) Cancer Research Workflows

  2026-08-18

  MLN8237 (Alisertib) combines nanomolar Aurora A potency with strong Aurora B selectivity for studies of mitosis, apoptosis, and tumor progression. This workflow-focused guide shows how to connect target expression, exposure design, orthogonal readouts, and in vivo translation, with particular relevance to retinoblastoma models.

• Y-27632 dihydrochloride in ISC Organoids

  2026-08-17

  Y-27632 dihydrochloride provides transient ROCK pathway control for post-passaging recovery, cytoskeletal analysis, and organoid assay standardization. This guide connects that practical workflow to new findings on Paneth cell-dependent intestinal stem cell aging while separating survival support from biological interpretation.

• N-octanoyl-L-Homoserine lactone Workflows

  2026-08-17

  Use C8-HSL to connect quorum-sensing chemistry with reproducible biofilm, virulence, and host-cell assays. This practical guide covers concentration design, pathway-aware readouts, formulation, and troubleshooting for microbial pathogenicity and infection biology research.

8557 records 1/571 page Next 12345 下5页 Last page